Gene · 10642
Papers3,895
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,895
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Uncovering biomarkers and pathways in oral squamous cell carcinoma through integrated lncRNA-mRNA regulatory network analysis. | Discov Oncol | 2025 | 40760230 | PubTator, text mining | PubMed |
| AMF30a promotes survival and function of human corneal endothelial cells by regulating TGF-β/ROCK/HIPPO pathway. | Sci Rep | 2025 | 40753109 | PubTator, text mining | PubMed |
| "Molecular pigeon" network of lncRNA and miRNA: decoding metabolic reprogramming in patients with lung cancer. | Front Oncol | 2025 | 40746614 | PubTator, text mining | PubMed |
| Comprehensive analysis of cholesterol metabolism-related genes in prostate cancer: integrated analysis of single-cell and bulk RNA sequencing. | Discov Oncol | 2025 | 40736630 | PubTator, text mining | PubMed |
| Thermodynamics and Binding Mechanism of Insulin-like Growth Factor Binding Protein 1 (IGF2BP1) and Y3 RNA Interaction. | Biochemistry | 2025 | 40736167 | PubTator, text mining | PubMed |
| Welander distal myopathy-associated TIA1 mutation exacerbates P-body and stress granule dynamics concomitant with nucleolar stress under oxidative stress. | Genes Dis | 2025 | 40735695 | PubTator, text mining | PubMed |
| RNA m6A modification: a key regulator in normal and malignant processes. | Cell Investig | 2025 | 40734692 | PubTator, text mining | PubMed |
| FTO-mediated MMP1 m6A modification promotes osteogenic differentiation of bone marrow mesenchymal stem cells via the ERK pathway in congenital scoliosis. | Sci Rep | 2025 | 40731128 | PubTator, text mining | PubMed |
| Gambogic acid induces ferroptosis and suppresses colorectal cancer progression by modulating the m6A modification of p62. | Cell Signal | 2025 | 40721064 | PubTator, text mining | PubMed |
| Peptide Drug: Design and Clinical Applications. | MedComm (2020) | 2025 | 40717901 | PubTator, text mining | PubMed |
| Long Noncoding RNA MNX1-AS1 Promotes Tumorigenesis of Breast Cancer by Binding IGF2BP1 to Activate c-MET. | Mol Carcinog | 2025 | 40705956 | PubTator, text mining | PubMed |
| Inhibitor Affinity Differs among Clinical Variants of IMP Metallo-β-Lactamases: Analysis and Implications for Inhibitor Design. | ACS Infect Dis | 2025 | 40704846 | PubTator, text mining | PubMed |
| Carbapenem-Resistant Gram-Negative Bacteria in Hospitalized Patients: A Five-Year Surveillance in Italy. | Infect Dis Rep | 2025 | 40700322 | PubTator, text mining | PubMed |
| Serum exosomal hsa-let-7f-5p: A potential diagnostic biomarker for metastatic pancreatic cancer detection. | World J Gastroenterol | 2025 | 40678708 | PubTator, text mining | PubMed |
| IGF2BP1 promotes the progression of head and neck squamous cell carcinoma by activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition. | World J Surg Oncol | 2025 | 40660234 | PubTator, text mining | PubMed |
| METTL3 mediates m6A methylation modification of ULBP2 and affects the progression of cervical cancer. | Hereditas | 2025 | 40640957 | PubTator, text mining | PubMed |
| Down-regulation of human-specific lncRNA TMEM9B-AS1 in skeletal muscle of people with type 2 diabetes affects ribosomal biogenesis. | Sci Adv | 2025 | 40632859 | PubTator, text mining | PubMed |
| AVJ16 inhibits lung carcinoma by targeting IGF2BP1. | Oncogene | 2025 | 40629079 | PubTator, text mining | PubMed |
| The Role of EZH2 in Initiating Epigenetic Regulation of CRSwNP. | J Inflamm Res | 2025 | 40626038 | PubTator, text mining | PubMed |
| Role and Mechanism of Rho-Associated Coiled-Coil Containing Protein Kinase 1 (ROCK1) in Lipopolysaccharide-Evoked Pneumonia in Mice and Inflammatory Injuries in WI-38 Fibroblasts. | Circ J | 2025 | 40619218 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10642/papers?page=10